Skip to content

Efficacy of Central-Peripheral Magnetic Stimulation in Lower Extremity Motor Function Recovery in Stroke Patients: A Multimodal Assessment-Based Study

Efficacy of Central-Peripheral Magnetic Stimulation in Lower Extremity Motor Function Recovery in Stroke Patients: A Multimodal Assessment-Based Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600127152
Enrollment
Unknown
Registered
2026-06-25
Start date
2026-01-05
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stroke

Interventions

rTMS group:The rTMS group received rTMS treatment and sham rPMS stimulation.
rPMS group:The rPMS group received rPMS treatment and sham rTMS stimulation.
CPMS group:The CPMS group underwent rTMS and rPMS combined stimulation therapy.

Sponsors

Haikou People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Conforming to the diagnostic criteria in the "Diagnostic Points of Major Cerebrovascular Diseases in China 2019" and confirmed by head CT or MRI; 2. First stroke, or with a history of stroke but without residual neurological dysfunction, with a disease course of 2 weeks to 6 months; 3. Patient's vital signs are basically stable, with no recent progressive worsening of cerebrovascular disease, able to cooperate in completing rehabilitation training, and able to clearly express training sensations; 4. Affected lower extremity Brunnstrom stage II-IV, with lower extremity dysfunction (FMA-LE < 27 points); 5. Age 30 to 70 years; 6. Affected lower extremity modified Ashworth scale <= 2 grade; 7. Informed consent signed by the patient or their authorized representative.

Exclusion criteria

Exclusion criteria: 1. Presence of cardiac pacemaker, intracranial metal implant, history of coronary artery stent insertion, or other contraindications to rTMS; 2. Presence of lumbar metal implant or other contraindications to rPMS; 3. History of epileptic seizure or family history of epilepsy; 4. Comorbid severe primary diseases of the heart, lung, liver, kidney, or hematopoietic system; 5. Pregnant state.

Design outcomes

Primary

MeasureTime frame
Changes in Task State Oxyhemoglobin (HbO) Concentration;Root Mean Square (RMS);Integrated Electromyography (iEMG);Gait parameters of the affected lower limb: stride length, stride length, stride time, maximum hip flexion angle, maximum knee flexion angle, maximum ankle dorsiflexion angle.;

Secondary

MeasureTime frame
Fugl MeyerLower-Extremity Score;Postural Assessment Scale for Stroke Patients Score;Modified Barthel Index Score;

Countries

China

Contacts

Public ContactShuyin Li/ Zhenhua Song

Haikou People's Hospital

a1974781010@163.com+86 133 2208 4942

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 3, 2026